semaglutide and eating disorders rise amid popular weight loss medications Wegovy Zepbound—Is there a link? Home - Eating Disorders Resource

2046) and nucleophosmin (NPM

Ethics declarations Conflict of interest All authors (Ravi Maharjan, Duck soo Lim, Hye Jung Baik, Ha Eun Park, Min-Soo Kim, Ki Hyun Kim, and Seong Hoon Jeong) declare that they have no conflict of interest

For example, concurrent use with corticosteroids may amplify the potential for fluid retention or electrolyte imbalance, particularly sodium and water retention

See additional terms and conditions for Chegg Study or Chegg Study Pack on Chegg.com Show transcribed image text Question: Semaglutide differs from GLP-1 in just two amino acids where modifications were made to increase the half-life of the peptide drug in the body and minimize the drug's immunogenicity